Obstructive sleep apnoea, resistant hypertension and renal denervation
Obstructive sleep apnea, hard-to-treat high blood pressure, and kidney nerve treatment
AI simplified
Abstract
Obstructive sleep apnoea (OSA) was diagnosed in 64% of patients with resistant hypertension.
- Sleep apnoea affects 5% to 10% of the general population.
- OSA is the most prevalent condition linked to resistant hypertension.
- OSA is associated with an increased risk of cardiovascular events, including heart disease, heart failure, stroke, and death.
- Potential mechanisms for the link between OSA and cardiovascular disease include oxidative stress, inflammation, and dysfunction of blood vessel lining.
- Continuous positive airway pressure (CPAP) is an effective treatment for severe OSA and its related health risks.
AI simplified